Single-dose treatment reduces COVID-19 hospitalization risk by half for high-risk patients in phase 3 trial
A single-dose of the antiviral drug peginterferon lambda reduced by half the risk of hospitalization or a visit to the Emergency Department due to COVID-19, according to a study published today in the New England Journal ...
Feb 8, 2023
0
123